CLINICAL_TRIALS
ClinicalTrials.gov record update
Phase II Study of Pemetrexed or Nab-paclitaxel With Pembrolizumab in Elderly (>/= 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT04754815
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:38:44.654556+00:00
- Published At
- 2022-03-29T00:00:00+00:00
- Record Updated At
- 2022-03-29
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Non Small Cell Lung Cancer", "Advanced Lung Non-Small Cell Carcinoma", "PD-L1 Gene Mutation"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-03-29"- protocolSection.identificationModule.nctId
"NCT04754815"- protocolSection.identificationModule.officialTitle
"Phase II Study of Pemetrexed or Nab-paclitaxel With Pembrolizumab in Elderly (\u003e/= 75 Years) Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)"- protocolSection.statusModule.overallStatus
"WITHDRAWN"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.